Company: CNTB
Filing Date: 2025-09-10
Form Type: POS AM
Source: 0001193125-25-200186
Chunk: 107

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-09-10
Form: POS AM
Chunk 107
---
 to the terms and conditions of the Sales Agreement on a daily
basis or as otherwise agreed upon by us and the Sales Agent. We will designate the maximum number or amount of Ordinary Shares to be sold through the Sales Agent on a daily basis or otherwise determine such maximum number or amount together with the
Sales Agent. Subject to the terms and conditions of the Sales Agreement, the Sales Agent will use commercially reasonable efforts consistent with its normal trading and sales practices to sell on our behalf all of the Ordinary Shares requested to be
sold by us. We may instruct the Sales Agent not to sell Ordinary Shares if the sales cannot be effected at or above a minimum price designated by us in any such instruction. The Sales Agent or we may suspend the offering of the Ordinary Shares being
made under the Sales Agreement upon proper notice to the other parties. The Sales Agent and we each have the right, by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement at each party’s sole discretion
at any time. The offering of the Ordinary Shares pursuant to the Sales Agreement will otherwise terminate upon the termination of the Sales Agreement as provided therein.

The compensation payable to the Sales Agent will be an amount of up to 3.0% of the gross proceeds of any Ordinary Shares sold
through it pursuant to the Sales Agreement and we will reimburse the Sales Agent for certain expenses, including fees and disbursements of legal counsel. In accordance with Financial Industry Regulatory Authority, Inc. Rule 5110, these reimbursed
fees and expenses are deemed sales compensation to the Sales Agent in connection with this offering. We estimate that the total expenses of the offering payable by us, excluding compensation payable to the Sales Agent under the Sales Agreement, will
be approximately $250,000.

The remaining sales proceeds, after deducting any expenses payable by us and any transaction
fees imposed by any governmental, regulatory or self-regulatory organization in connection with the sales of the Ordinary Shares, will equal our net proceeds for the sale of such Ordinary Shares.

The Sales Agent will provide written confirmation to us no later than the next succeeding trading day on Nasdaq after each
such day on which Ordinary Shares are sold under the Sales Agreement. Each confirmation will include the amount or number of Ordinary Shares sold on that day, the volume-weighted average price of the Ordinary Shares sold, the percentage of the daily
trading volume and the net proceeds to us from such sales.

Settlement for sales of Ordinary Shares will occur, unless the
parties agree otherwise, on